Back to results
US 10,117,929 B1Granted
Nucleic acid-based adjuvant and porcine vaccine composition including the same
AssigneeNational Pingtung University of Science and Technology
InventorsHso-Chi Chaung, Guan-Ming Ke, Mei-Li Wu
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nucleic acid-based adjuvant and a porcine vaccine composition including the same. The nucleic acid-based adjuvant, which is a nucleic acid fragment consisting of a sequence listing as SEQ ID NO: 1, can be used as the nucleic acid-based adjuvant of a vaccine composition, thereby elevating the protective ability of the porcine vaccine composition.
Claims1
A porcine vaccine composition, comprising:
- an antigen, comprising an inactivated virus strain, wherein the inactivated virus strain comprises gE gene-knockout pseudorabies (PR) virus strain or chemically inactivated porcine epidemic diarrhea (PED) virus strain;
- and
- a nucleic acid-based adjuvant consisting of a nucleic acid fragment having a sequence listing as SEQ ID NO:
- 1.
1 more element
Dependencies are inferred from the claim text.